No significant difference in GA-related pain noted between treatment and control groups on day 15
After 2 weeks of therapy, a persistent decrease in serum CRP levels was observed in the two groups (− 0.3 [IQR, − 1.1 to 0] vs − 0.5 [IQR, − 1.4 to − 0.2]; 